AVALYN PHARMA INC.
Profile
Company Names
AVALYN PHARMA INC.
GENOA PHARMACEUTICALS, INC.
Addresses
701 PIKE STREET, SUITE 1500, SEATTLE, WA 98101
701 PIKE STREET, SUITE 1500, SEATTLE, WA 98101
C/O 12670 HIGH BLUFF DRIVE, SAN DIEGO, CA 92130
12636 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA 92130
Phone Numbers
(206) 707-0340
(619) 992-6488
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$245,069,287.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-09-22
$189,182,622.00
$189,182,622.00
$0.00
Equity
3
2020-04-24
$35,499,998.00
$35,695,957.00
$195,959.00
Equity
2
2017-03-13
$18,207,187.00
$64,915,611.00
$46,708,424.00
Equity
1
2011-10-23
$2,179,480.00
$2,179,480.00
$0.00
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA
AYNECHI
DIRECTOR
THESAN PHARMACEUTICALS, INC.
| IRHYTHM TECHNOLOGIES, INC.
| ANAPTYSBIO INC
| GENOA PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| AVALYN PHARMA INC.
| SPRUCE BIOSCIENCES, INC.
| ARISTEA THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| REZO THERAPEUTICS, INC.
| RAY THERAPEUTICS, INC.
JILL
CARROLL
DIRECTOR
MICHAEL
J.
KAMDAR
EXECUTIVE OFFICER, DIRECTOR
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
ROBERT
MITTENDORFF
DIRECTOR
PETER
MOLDT
DIRECTOR
CARDEAS PHARMA CORP
| ALLAKOS INC.
| BIOCLIN THERAPEUTICS, INC.
| CORVUS PHARMACEUTICALS, INC.
| VASCULOX, INC.
| E-SCAPE BIO, INC.
| TIOMA THERAPEUTICS, INC.
| BOLT BIOTHERAPEUTICS, INC.
| VIEWPOINT THERAPEUTICS, INC.
| OUTPOST MEDICINE, LLC
| SWIFT HEALTH SYSTEMS INC.
| ALIGOS THERAPEUTICS, INC.
| ESCAPE BIO, INC.
| AVALYN PHARMA INC.
A.
BRUCE
MONTGOMERY
EXECUTIVE OFFICER, DIRECTOR
NIALL
O-DONNELL
DIRECTOR
LYRIC PHARMACEUTICALS INC.
| 3X5 RIVERVEST FUND II, L.P.
| ARCHER SEED FUND, L.P.
| GENOA PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND IV, L.P.
| CURZION PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| AVALYN PHARMA INC.
| MIRUM PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND V, L.P.
| SPARROW PHARMACEUTICALS, INC.
| WUGEN, INC.
KETAN
PATEL
DIRECTOR
INTELLEFLEX CORP
| SHOPWELL SOLUTIONS, INC.
| ACLARIS THERAPEUTICS, INC.
| RAINMAKER HOLDINGS II, LLC
| IVENIX, INC.
| GENOA PHARMACEUTICALS, INC.
| NFLECTION THERAPEUTICS, INC.
| MENLO THERAPEUTICS, INC.
| AMPHORA MEDICAL, INC.
| FOREST CITY REALTY TRUST, INC.
| AZAD ALLIANCE 2019 LLC
| AVALYN PHARMA INC.
| RALLYBIO HOLDINGS, LLC
| REDIRECT HEALTH, LLC
| FOREST CITY ENTERPRISES, L.P.
| AVIVOMED INC.
| ABK BIOMEDICAL INC
| FC 1275 NJ MEMBER LLC
| FC TOD MF II HOLDINGS LLC
| FC TOD BTR HOLDINGS I LLC
| COMANCHE BIOPHARMA CORP.
| LOS ANGELES BIOSCIENCES, INC.
| RAINMAKER CAPITAL LLC
HEATHER
PRESTON
DIRECTOR
RICHARD
G.
VINCENT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

